Oncology & Cancer

Pancreatic cancer diagnosis under review

A team of researchers of the UPV/EHU together with researchers from the Hospital ClĂ­nico of Barcelona have produced a bibliographical review that summarises the data currently existing on the markers for pancreatic cancer, ...

Oncology & Cancer

Early biomarker for pancreatic cancer identified

Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center have identified a new biomarker and therapeutic target for pancreatic cancer, an often-fatal disease for which there is currently ...

Oncology & Cancer

Advanced pancreatic tumors depend on continued oncogene activity

Researchers at Dana-Farber Cancer Institute have shown that advanced pancreatic cancers in mice can't survive without continued expression of a mutant oncogene that "rewires" key metabolic pathways to fuel the cancer cells.

Oncology & Cancer

Combination therapy may enhance gemcitabine activity

Oncologists who treat patients with pancreatic cancer may be one step closer to understanding why gemcitabine, the only currently available treatment, works in some cases but not in others, according to a paper in Cancer ...

Oncology & Cancer

EGFR essential for the development of pancreatic cancer

The epidermal growth factor receptor (EGFR) gene is essential for KRAS-driven pancreatic cancer development, according to study results presented at the Second AACR International Conference on Frontiers in Basic Cancer Research, ...

page 10 from 11